Abstract
HIV-1 is cytopathic for CD4+T lymphocytesin vitroand this property of HIV-1 is generally considered to account for some of itsin vivocytopathogenicity. Thus, the extent of lymphocyte depletion correlates with the level of viremia whereas low levels of viral replication are typically associated with stable lymphocyte levels and asymptomatic infection such as is observed in non-progressors. Here, we describe a non-progressor who did not fit this general pattern in that CD4+T lymphocyte homeostasis was maintained in the face of high-level viral replication. Biological viral isolates from this patient replicated in primary lymphocytes without inducing cytopathicity. Because this phenotype is reminiscent of Vpr-deleted viruses, we examined the contribution of the Vpr gene to the viral phenotype. Vpr alleles derived from this patient contained both premature stop codons and an unusual Q3R polymorphism. Insertion of patient-derived Vpr alleles or a Q3R substitution into a cytopathic HIV-1 clone resulted in a marked impairment of cytopathicity without affecting viral replication efficiency. The effect of Vpr on cytopathicity was unrelated to reported activities of Vpr including virion association, interaction with uracil DNA glycosylase, G2arrest, or enhancement of macrophage infection but correlated with the ability of Vpr to induce host cell apoptosis. This study suggests the presence of a determinant ofin vivocytopathogenicity within HIV-1 Vpr and further indicates that viral replication can be uncoupled from cytopathicityin vitroandin vivo.
References
34
Referenced
86
10.7326/0003-4819-126-12-199706150-00003
10.1038/35073648
10.1128/jvi.70.3.1340-1354.1996
10.1128/JVI.74.22.10690-10698.2000
10.1038/323725a0
10.1128/jvi.71.10.7478-7487.1997
-
B Asjo, L Morfeldt-Manson, J Albert, G Biberfeld, A Karlsson, K Lidman, E M Fenyo Lancet 2, 660–662 (1986).
(
10.1016/S0140-6736(86)90169-8
) / Lancet by Asjo B (1986) 10.1016/0042-6822(89)90266-3
10.1023/A:1009636530839
10.1097/00002030-199410000-00008
10.1038/nm0396-274
10.1016/S0092-8674(00)80110-5
10.1056/NEJM199501263320405
10.1126/science.270.5238.988
10.1128/JVI.74.9.4361-4376.2000
10.1016/S0022-3476(05)80430-5
10.1001/jama.1992.03480110060034
10.1038/12433
10.1128/jvi.71.6.4842-4846.1997
10.1128/jvi.69.2.882-888.1995
10.1038/3992
10.1016/0014-5793(94)01074-9
- M Stevenson Curr Top Microbiol Immunol 261, 1–30 (2002). / Curr Top Microbiol Immunol by Stevenson M (2002)
10.1080/13550280290049552
10.1016/S0952-7915(99)80078-8
10.1128/JVI.72.5.3646-3657.1998
10.1128/jvi.69.9.5743-5753.1995
10.1128/JVI.72.4.3472-3474.1998
10.1006/viro.1996.0471
10.1016/0165-2478(96)02548-5
10.1128/JVI.75.12.5646-5655.2001
10.1089/088922200309476
10.1038/35071111
10.1097/00002030-199907300-00023
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 28, 2002, 6:26 p.m.) |
Deposited | 2 years, 4 months ago (April 23, 2023, 7:40 p.m.) |
Indexed | 6 days, 9 hours ago (Aug. 30, 2025, 12:26 p.m.) |
Issued | 23 years, 2 months ago (July 1, 2002) |
Published | 23 years, 2 months ago (July 1, 2002) |
Published Online | 23 years, 2 months ago (July 1, 2002) |
Published Print | 23 years, 1 month ago (July 9, 2002) |
@article{Somasundaran_2002, title={Evidence for a cytopathogenicity determinant in HIV-1 Vpr}, volume={99}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.142313699}, DOI={10.1073/pnas.142313699}, number={14}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Somasundaran, Mohan and Sharkey, Mark and Brichacek, Beda and Luzuriaga, Katherine and Emerman, Michael and Sullivan, John L. and Stevenson, Mario}, year={2002}, month=jul, pages={9503–9508} }